ArticleNeuro-oncology advances

Delta-like ligand 3 expression in isocitrate dehydrogenase-mutant and isocitrate dehydrogenase-wildtype glioma is largely retained at recurrence, supporting its potential as a therapeutic target.

Rosa Luning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.